Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1440306
rs1440306
LOC107986306
A 0.800 GeneticVariation GWASCAT A genome-wide association study (GWAS) for bronchopulmonary dysplasia. 23897914

2013
dbSNP: rs1440306
rs1440306
LOC107986306
A 0.800 GeneticVariation GWASDB A genome-wide association study (GWAS) for bronchopulmonary dysplasia. 23897914

2013
dbSNP: rs556493
rs556493
STXBP5
A 0.800 GeneticVariation GWASDB A genome-wide association study (GWAS) for bronchopulmonary dysplasia. 23897914

2013
dbSNP: rs556493
rs556493
STXBP5
A 0.800 GeneticVariation GWASCAT A genome-wide association study (GWAS) for bronchopulmonary dysplasia. 23897914

2013
dbSNP: rs72791417
rs72791417
CTNNA3
A 0.800 GeneticVariation GWASCAT A genome-wide association study (GWAS) for bronchopulmonary dysplasia. 23897914

2013
dbSNP: rs72791417
rs72791417
CTNNA3
A 0.800 GeneticVariation GWASDB A genome-wide association study (GWAS) for bronchopulmonary dysplasia. 23897914

2013
dbSNP: rs1245560
rs1245560
SPOCK2
0.710 GeneticVariation GWASDB Fine mapping confirmed the association of rs1245560 with bronchopulmonary dysplasia in both white and African populations with adjusted odds ratios of 2.96 (95% confidence interval [CI], 1.37-6.40) and 4.87 (95% CI, 1.88-12.63), respectively. 21836138

2011
dbSNP: rs1245560
rs1245560
SPOCK2
0.710 GeneticVariation BEFREE Fine mapping confirmed the association of rs1245560 with bronchopulmonary dysplasia in both white and African populations with adjusted odds ratios of 2.96 (95% confidence interval [CI], 1.37-6.40) and 4.87 (95% CI, 1.88-12.63), respectively. 21836138

2011
dbSNP: rs372271081
rs372271081
NBL1 ; MICOS10-NBL1
0.700 GeneticVariation GWASCAT Ancestry and genetic associations with bronchopulmonary dysplasia in preterm infants. 30113228

2018
dbSNP: rs1010419
rs1010419
AGBL1
0.700 GeneticVariation GWASDB Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia. 21836138

2011
dbSNP: rs10152333
rs10152333
AGBL1 ; AGBL1-AS1
0.700 GeneticVariation GWASDB Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia. 21836138

2011
dbSNP: rs1049269
rs1049269
SPOCK2
0.700 GeneticVariation GWASDB Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia. 21836138

2011
dbSNP: rs2701405
rs2701405
AGBL1
0.700 GeneticVariation GWASDB Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia. 21836138

2011
dbSNP: rs4829242
rs4829242
IL1RAPL1
0.700 GeneticVariation GWASDB Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia. 21836138

2011
dbSNP: rs5927969
rs5927969
DMD
0.700 GeneticVariation GWASDB Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia. 21836138

2011
dbSNP: rs6526874
rs6526874
IL1RAPL1
0.700 GeneticVariation GWASDB Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia. 21836138

2011
dbSNP: rs7887541
rs7887541
DMD
0.700 GeneticVariation GWASDB Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia. 21836138

2011
dbSNP: rs6265
rs6265
BDNF ; BDNF-AS
0.070 GeneticVariation BEFREE The positive association of BNDF Val66Met with high BMI values replicates previous findings in patients with SCZ and indicates the BDNF Val66Met genotype as a potential risk factor for obesity and insulin resistance measures in patients with BPD receiving antipsychotics as well. 25874530

2015
dbSNP: rs759834365
rs759834365
BDNF ; BDNF-AS
0.070 GeneticVariation BEFREE The positive association of BNDF Val66Met with high BMI values replicates previous findings in patients with SCZ and indicates the BDNF Val66Met genotype as a potential risk factor for obesity and insulin resistance measures in patients with BPD receiving antipsychotics as well. 25874530

2015
dbSNP: rs6265
rs6265
BDNF ; BDNF-AS
0.070 GeneticVariation BEFREE Overall, there was no significant difference in allelic distribution of Val66Met polymorphism between patients and controls with a pooled OR = 1.03 (95% CI 0.98, 1.08) although there was a trend towards association between Val66Met polymorphism and BPD in Caucasians with an OR of 1.08 (95% CI 1.00, 1.16). 25539739

2014
dbSNP: rs759834365
rs759834365
BDNF ; BDNF-AS
0.070 GeneticVariation BEFREE Overall, there was no significant difference in allelic distribution of Val66Met polymorphism between patients and controls with a pooled OR = 1.03 (95% CI 0.98, 1.08) although there was a trend towards association between Val66Met polymorphism and BPD in Caucasians with an OR of 1.08 (95% CI 1.00, 1.16). 25539739

2014
dbSNP: rs6265
rs6265
BDNF ; BDNF-AS
0.070 GeneticVariation BEFREE The association between Val66Met polymorphism and BPD, treatment response to mood stabilizers, was estimated. 22548711

2012
dbSNP: rs759834365
rs759834365
BDNF ; BDNF-AS
0.070 GeneticVariation BEFREE The association between Val66Met polymorphism and BPD, treatment response to mood stabilizers, was estimated. 22548711

2012
dbSNP: rs6265
rs6265
BDNF ; BDNF-AS
0.070 GeneticVariation BEFREE Previous studies have suggested that the Val66Met (also known as rs6265 or G196A) variant of BDNF is associated with bipolar disorder (BPD), but the results have been inconclusive. 19330778

2010
dbSNP: rs759834365
rs759834365
BDNF ; BDNF-AS
0.070 GeneticVariation BEFREE Previous studies have suggested that the Val66Met (also known as rs6265 or G196A) variant of BDNF is associated with bipolar disorder (BPD), but the results have been inconclusive. 19330778

2010